| Item Type | Name |
|
Concept
|
Neuroblastoma
|
|
Academic Article
|
Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.
|
|
Academic Article
|
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
|
|
Academic Article
|
The regulation of angiogenesis in neuroblastoma.
|
|
Academic Article
|
Methylation-associated silencing of the heat shock protein 47 gene in human neuroblastoma.
|
|
Academic Article
|
Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
|
|
Academic Article
|
SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix.
|
|
Academic Article
|
Thrombospondin-1 peptide ABT-510 combined with valproic acid is an effective antiangiogenesis strategy in neuroblastoma.
|
|
Academic Article
|
Prominent microvascular proliferation in clinically aggressive neuroblastoma.
|
|
Academic Article
|
'Cross-talk' between Schwannian stroma and neuroblasts promotes neuroblastoma tumor differentiation and inhibits angiogenesis.
|
|
Academic Article
|
Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
|
|
Academic Article
|
Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.
|
|
Academic Article
|
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
|
|
Academic Article
|
The quinoxaline anti-tumor agent (R+)XK469 inhibits neuroblastoma tumor growth.
|
|
Academic Article
|
Presence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumors.
|
|
Academic Article
|
Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.
|
|
Academic Article
|
Valproic acid shows a potent antitumor effect with alteration of DNA methylation in neuroblastoma.
|
|
Academic Article
|
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome.
|
|
Academic Article
|
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.
|
|
Academic Article
|
Cross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenografts.
|
|
Academic Article
|
Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells.
|
|
Academic Article
|
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system.
|
|
Academic Article
|
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
|
|
Academic Article
|
Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
|
|
Academic Article
|
Secreted protein acidic and rich in cysteine (SPARC) induces lipotoxicity in neuroblastoma by regulating transport of albumin complexed with fatty acids.
|
|
Academic Article
|
Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.
|
|
Academic Article
|
5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype.
|
|
Academic Article
|
5-Hydroxymethylcytosine Profiles in Circulating Cell-Free DNA Associate with Disease Burden in Children with Neuroblastoma.
|
|
Academic Article
|
5-hydroxymethylcytosine profiling of cell-free DNA identifies bivalent genes that are prognostic of survival in high-risk neuroblastoma.
|
|
Academic Article
|
T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.
|
|
Academic Article
|
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
|
|
Academic Article
|
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
|
|
Academic Article
|
5-Hydroxymethylcytosine Profiling of Cell-Free DNA Identifies Bivalent Genes That Are Prognostic of Survival in High-Risk Neuroblastoma.
|
|
Academic Article
|
Small-molecule inhibition of the METTL3/METTL14 complex suppresses neuroblastoma tumor growth and promotes differentiation.
|
|
Academic Article
|
Characterizing Relationships between T-cell Inflammation and Outcomes in Patients with High-Risk Neuroblastoma According to Mesenchymal and Adrenergic Signatures.
|